Nanozymes Based Biosensors for Detection of Biomarkers in Brain Diseases
Small · 2026
DOI: 10.1002/smll.202510732 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, 2026. Verfasst von Ling Teng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Precision Medicine Translational Research Center, Frontiers Science Center For Disease-related Molecular Network, …. Hauptthemen laut MEDLINE: Biosensing Techniques, Biomarkers, Brain Diseases, Nanostructures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 239 Literaturangaben. Gefördert von: National Science and Technology Major Project, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Brain diseases, including neurodegenerative disorders, brain tumors, and ischemic strokes, have shown significant threats to human neurological health and quality of life. With the aging population, the incidence of brain diseases continues to rise, further exacerbating public health issues. Traditional diagnostic methods, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), are hindered by limited image resolution and a high reliance on costly equipment. Single‐molecule detection technologies, such as digital ELISA, have shown great promise for improving sensitivity, but their complex procedures and high costs remain barriers. Nanozymes, nanomaterials with enzyme‐like activity, have emerged as a potential alternative. These materials offer high stability and lower costs in comparison with natural enzymes, making them ideal for portable, high‐throughput diagnostics. In this review, we mainly summarize the types and applications of nanozymes with peroxidase‐like activity and oxidase‐like activity in brain disease biomarker detection and discuss the challenges and future directions for their clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Precision Medicine Translational Research Center, Frontiers Science Center For Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Hubei University of Science and Technology, Xianning, Hubei, China.
- Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Shufen Li, Yongchao Yao, Weihua Zhuang, Wenchuang Hu
Förderung
- National Science and Technology Major Project
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Teng, L., Tan, H., Bai, W., Yu, X., Li, Q., Wang, C., Zhang, H., Li, S., Yao, Y., Zhuang, W., & Hu, W. (2026). Nanozymes Based Biosensors for Detection of Biomarkers in Brain Diseases. Small. https://doi.org/10.1002/smll.202510732
Vancouver
Teng L, Tan H, Bai W, Yu X, Li Q, Wang C, et al. Nanozymes Based Biosensors for Detection of Biomarkers in Brain Diseases. Small. 2026. doi:10.1002/smll.202510732
BibTeX
@article{Teng2026,
author = {Teng, Ling and Tan, Huiling and Bai, Weiyi and Yu, Xingzhi and Li, Qing and Wang, Caihui and Zhang, Hongyin and Li, Shufen and Yao, Yongchao and Zhuang, Weihua and Hu, Wenchuang},
title = {Nanozymes Based Biosensors for Detection of Biomarkers in Brain Diseases},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202510732}
}
EUVIMED